Development and validation of glycolysis‐related prognostic score for prediction of prognosis and chemosensitivity of pancreatic ductal adenocarcinoma-Reference-Cited by-同舟云学术

Development and validation of glycolysis‐related prognostic score for prediction of prognosis and chemosensitivity of pancreatic ductal adenocarcinoma

Published:2021-05-03 Issue:12 Volume:25 Page:5615-5627
ISSN:1582-1838
Container-title:Journal of Cellular and Molecular Medicine
language:en
Short-container-title:J Cell Mol Med

Author:

Zhang Xiu‐Ping¹^ORCID,Chen Qinjunjie²,Liu Qu¹,Wang Yang¹,Wang Fei¹,Zhao Zhi‐Ming¹,Zhao Guo‐Dong¹,Lau Wan Yee¹³,Gao Yu‐Zhen⁴,Liu Rong¹^ORCID

Affiliation:

1. Faculty of Hepato‐Biliary‐Pancreatic Surgery Chinese People’s Liberation Army (PLA) General Hospital Beijing China

2. Department of Hepatic Surgery IV The Eastern Hepatobiliary Surgery Hospital Second Military Medical University Shanghai China

3. Faculty of Medicine The Chinese University of Hong Kong Hong Kong China

4. Department of Clinical Laboratory Sir Run Run Shaw Hospital Zhejiang University School of Medicine Hangzhou China

Publisher

Wiley

Subject

Cell Biology,Molecular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jcmm.16573

Reference51 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

2. Programmed Cell Death Ligand-1 (PD-L1) and CD8 Expression Profiling Identify an Immunologic Subtype of Pancreatic Ductal Adenocarcinomas with Favorable Survival

3. Identification of Resistance Pathways Specific to Malignancy Using Organoid Models of Pancreatic Cancer

4. Long-term survival after resection of pancreatic cancer: A single-center retrospective analysis

5. MiR-194-5p in Pancreatic Ductal Adenocarcinoma Peritoneal Washings is Associated with Peritoneal Recurrence and Overall Survival in Peritoneal Cytology-Negative Patients

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of ARL4C in predicting prognosis and immunotherapy drug susceptibility in pan-cancer analysis;Frontiers in Pharmacology;2023-12-20

2. Early and late recurrence patterns of pancreatic ductal adenocarcinoma after pancreaticoduodenectomy: a multicenter study;International Journal of Surgery;2023-03-31

3. A novel online calculator to predict early recurrence and long-term survival of patients with resectable pancreatic ductal adenocarcinoma after pancreaticoduodenectomy: A multicenter study;International Journal of Surgery;2022-10

4. The immune escape signature predicts the prognosis and immunotherapy sensitivity for pancreatic ductal adenocarcinoma;Frontiers in Oncology;2022-09-06

5. AQP5 Is a Novel Prognostic Biomarker in Pancreatic Adenocarcinoma;Frontiers in Oncology;2022-05-10